MSI PI Mark Schleiss Receives NIH Grant


MSI PI Mark Schleiss (professor, Pediatrics) has received a $3.9M grant from the National Institutes of Health to investigate vaccine strategies against cytomegalovirus (CMV), an infection that causes birth defects and disabilities in babies. CMV is the most common such infection in the U.S. A story about this grant appears on the Medical School website: U of M Researcher Awarded $3.9 Million NIH Grant for CMV Studies.

Professor Schleiss uses MSI for his research into CMV.